Trinity Biotech plc (NASDAQ:TRIB) went down by -12.50% from its latest closing price compared to the recent 1-year high of $6.82. The company’s stock price has collected -19.47% of loss in the last five trading sessions. Press Release reported on 07/16/21 that Trinity Biotech Provides A Business Development Update For Q2 2021
Is It Worth Investing in Trinity Biotech plc (NASDAQ :TRIB) Right Now?
Trinity Biotech plc (NASDAQ:TRIB) scored a price-to-earnings ratio above its average ratio, recording 2.85 x from its present earnings ratio. Plus, the 36-month beta value for TRIB is at 1.64. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Trinity Biotech plc declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $7.00. TRIB currently public float of 15.85M and currently shorts hold a 1.79% ratio of that float. Today, the average trading volume of TRIB was 219.51K shares.
TRIB’s Market Performance
TRIB stocks went down by -19.47% for the week, with a monthly drop of -39.13% and a quarterly performance of -46.78%, while its annual performance rate touched -42.59%. The volatility ratio for the week stands at 12.18% while the volatility levels for the past 30 days are set at 7.44% for Trinity Biotech plc. The simple moving average for the period of the last 20 days is -30.40% for TRIB stocks with a simple moving average of -51.07% for the last 200 days.
Analysts’ Opinion of TRIB
ROTH Capital gave a rating of “Buy” to TRIB, setting the target price at $20 in the report published on July 29th of the previous year.
TRIB Trading at -38.88% from the 50-Day Moving Average
After a stumble in the market that brought TRIB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.32% of loss for the given period.
Volatility was left at 7.44%, however, over the last 30 days, the volatility rate increased by 12.18%, as shares sank -38.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -39.13% lower at present.
During the last 5 trading sessions, TRIB fell by -19.47%, which changed the moving average for the period of 200-days by -8.08% in comparison to the 20-day moving average, which settled at $2.5590. In addition, Trinity Biotech plc saw -52.23% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TRIB
Current profitability levels for the company are sitting at:
- +17.18 for the present operating margin
- +46.26 for the gross margin
The net margin for Trinity Biotech plc stands at -5.90. The total capital return value is set at 17.00, while invested capital returns managed to touch -5.97. Equity return is now at value -255.60, with -1.90 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 0.85, with the company’s debt to enterprise value settled at 0.66. The receivables turnover for the company is 4.34 and the total asset turnover is 0.78. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.08.